L. D. Carlton

Intravenous epoprostenol sodium does not increase hepatic microsomal enzyme activity in rats.

K. Brouwer, V. Schmith, L. D. Carlton, 1995, Prostaglandins.

The synthesis and antineoplastic activity of 2'-deoxy-nucleoside-cyanoboranes in murine and human culture cells.

I. Hall, B. Shaw, E. Hall, 1992, Anticancer research.

The Effects of Epoprostenol on Drug Disposition II: A Pilot Study of the Pharmacokinetics of Furosemide with and without Epoprostenol in Patients with Congestive Heart Failure

V. Schmith, L. D. Carlton, C. Mattson, 1996, Journal of clinical pharmacology.

Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol.

K. Brouwer, L. D. Carlton, G. Pollack, 1996, Journal of pharmaceutical sciences.